Abstract:Background: Mesenchymal stem cells (MSCs) have immunomodulatory properties and therapeutic effects on autoimmune diseases through their secreted factors, referred to as the secretome. However, the specific key factors of the MSC secretome and their mechanisms of action in immune cells have not been fully determined. Most in vitro experiments are being performed using immune cells, but experiments using natural killer (NK) cells have been neglected, and a few studies using NK cells have shown discrepancies in results. NK cells are crucial elements of the immune system, and adjustment of their activity is essential for controlling various pathological conditions. The aim of this study was to elucidate the role of the adipose tissue-derived stem cell (ADSC) secretome on NK cell activity. Methods: To obtain the ADSC secretome, we cultured ADSCs in medium and concentrated the culture medium using tangential flow filtration (TFF) capsules. We assessed NK cell viability and proliferation using CCK-8 and CFSE assays, respectively. We analyzed the effects of the ADSC secretome on NK cell activity and pathway-related proteins using a combination of flow cytometry, ELISA, cytotoxicity assay, CD107a assay, western blotting, and quantitative real-time PCR. To identify the composition of the ADSC secretome, we performed LC-MS/MS profiling and bioinformatics analysis. To elucidate the molecular mechanisms involved, we used mRNA sequencing to profile the transcriptional expression of human blood NK cells. Results: The ADSC secretome was found to restrict IL-2-mediated effector function of NK cells while maintaining proliferative potency. This effect was achieved through the upregulation of the inhibitory receptor CD96, as well as downregulation of activating receptors and IL-2 receptor subunits IL-2Rα and IL-2Rγ. These changes were associated with attenuated JAK-STAT and AKT pathways in NK cells, which were achieved through the upregulation of cytokine-inducible SH2-containing protein (CIS, encoded by Cish) and dual specificity protein phosphatase 4 (DUSP4). Furthermore, proteomic analysis revealed twelve novel candidates associated with the immunomodulatory effects of MSCs. Conclusions: Our findings reveal a detailed cellular outcome and regulatory mechanism of NK cell activity by the ADSC secretome and suggest a therapeutic tool for treating NK-mediated inflammatory and autoimmune diseases using the MSC secretome.

Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2.

[Human Adipose Derived Stem Cells Suppress Lymphocyte Proliferation Induced by Cellular or Nonspecific Mitogenic Stimuli].

Immunomodulative Effects of Mesenchymal Stem Cells Derived from Human Embryonic Stem Cells in Vivo and in Vitro

Primary Study Of Immunological Properties Of Adipose Derived Stem Cells

Immunosuppression of Human Adipose-Derived Stem Cells on T Cell Subsets via the Reduction of NF-kappaB Activation Mediated by PD-L1/PD-1 and Gal-9/TIM-3 Pathways.

Adipogenic differentiation alters the immunoregulatory property of mesenchymal stem cells through BAFF secretion.

Immunosupressive Property of Mesenchymal Stem Cells (mscs) in Mixed Lymphocyte Reactions in Vitro.

Suppressive Effect Mediated by Human Adipose-Derived Stem Cells on T Cells Involves the Activation of JNK.

Culture and Properties of Adipose-Derived Mesenchymal Stem Cells: Characteristics in Vitro and Immunosuppression in Vivo

Immunomodulatory abilities of bone marrow-derived and adipose-derived mesenchymal stem cells

Characteristics and Immunomodulating Functions of Adipose-Derived and Bone Marrow-Derived Mesenchymal Stem Cells Across Defined Human Leukocyte Antigen Barriers

Enhanced potent immunosuppression of intracellular adipose tissue-derived stem cell extract by priming with three-dimensional spheroid formation

[Inflammatory Priming Adipose Derived Stem Cells Significantly Inhibit the Proliferation of Peripheral Blood Mononuclear Cells].

The Interaction Between Mesenchymal Stem Cells and the Immune System

Conditioned Medium from Adipose-Derived Stem Cell Inhibits Jurkat Cell Proliferation Through TGF-β1 and P38/mapk Pathway.

Soluble molecules are key in maintaining the immunomodulatory activity of murine mesenchymal stromal cells.

Immune regulatory effect of human adipose-derived mesenchymal stem cells

ADSC secretome constrains NK cell activity by attenuating IL-2-mediated JAK-STAT and AKT signaling pathway via upregulation of CIS and DUSP4

Human Adipose Tissue-Derived Mesenchymal Stromal Cells Inhibit CD4+ T Cell Proliferation and Induce Regulatory T Cells as Well as CD127 Expression on CD4+CD25+ T Cells

Activated Mesenchymal Stromal Cells Process and Present Antigens Regulating Adaptive Immunity

Adipose-derived stem cells ameliorate atopic dermatitis by suppressing the IL-17 expression of Th17 cells in an ovalbumin-induced mouse model